Work

Introduction to the issue: acute pancreatitis and related metabolic complications

Year: 2024

Type: editorial

Abstract: Acute pancreatitis (AP) is among the most common gastrointestinal causes of hospitalization.In 2018, there were 288,220 hospitalizations in the United States where AP was listed as the primary diagnosis 1 .Historically, the management of AP (and related clinical research) has largely focused on the acute phase of disease (e.g., predicting disease severity, fluid resuscitation, diet, organ failure, and local complications).Similarly, basic science research has focused mainly on understanding the mechanisms of initiation of pancreatic injury and severity of AP.Long-term metabolic sequalae of AP including diabetes and/or exocrine pancreatic insufficiency were only considered in the context of risk due to pancreatic necrosis in the setting of moderate or severe AP.The Revised Atlanta Classification framework has been instrumental in standardizing the nomenclature for diagnosis and local complications 2 , allowing for comparison of data between different studies.

Source: Current Opinion in Gastroenterology

DOI: 10.1097/mog.0000000000001044

Authors: Dhiraj Yadav, Phil A. Hart, Melena Bellin

Institutions: University of Pittsburgh Medical Center, The Ohio State University Wexner Medical Center, University of Minnesota, University of Minnesota Children's Hospital

Language: English

Topic: Pancreatitis Pathology and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases